Vaxcyte, Inc. — Director's Dealing 2020

Dec 30, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Vaxcyte, Inc. (PCVX)
CIK: 0001649094
Period of Report: 2020-12-28

Reporting Person: PICKERING GRANT (Director, President & CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-12-28	Common Stock	M	5500	$1.79	Acquired	578691	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-12-28	Stock Option (right to buy)	$1.79	M	5500	Disposed	2027-05-17	Common Stock (5500)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	355660	Indirect

Footnotes

F1: 1/4 of the shares subject to the option vested on March 4, 2018, and 1/48 of the shares vest monthly thereafter.